Academy of Immunohistochemistry

Program

09.00 – 10.00
Registration and coffee
10.00 – 10.15
Janusz Ryś – Opening remarks
10.15 – 11.00
M. Miettinen – The most important innovations in immunohistochemistry that have changed cancer diagnostics in the last decade
11.00 – 11.45
J. Hornick – Next-generation immunohistochemistry for soft tissue tumors and beyond
11.45 – 12.30
O. Carpen – Diagnostic Molecular Pathology in the next decade
12.30 – 13.30
Lunch
13.30 – 14.15
A. Bellizzi – Differentiating the Undifferentiated: Algorithmic IHC Approach
14.15 – 15.00
A. Malpica – Useful IHC algorithms for gynecological pathology
15.00 – 15.45
P. Dundr – Diagnostic molecular pathology of uterine mesenchymal tumors
15.45 – 16.15
Coffee Break
16.15 – 17.00
A. Malpica – Germ Cell Tumors of the Ovary. A Practical Review
17.00 – 17.45
J. Stanek – Immunohistochemistry in placental pathology
17.45 – 18.30
A. Kowalewski and Ł. Szylberg – Immunohistochemical and molecular diagnostics tailoring personalized ovarian cancer therapy

08.30 – 09.15
A. Porwit – EBV related lymphomas and other EBV related lymphoid proliferations
09.15 – 10.00
M. Prochorec-Sobieszek – T-cell lymphomas – immunohistochemical and molecular approach
10.00 – 10.30
M. Tyburczy – New technologies in the genomic evaluation of lymphomas
10.30 – 11.00
Coffee Break
11.00 – 11.45
T. Mentzel – Immunohistochemistry in differential diagnosis of spindle cell tumors in skin and subcutis
11.45 – 12.30
T. Mentzel – Pitfalls in the diagnosis of melanocytic neoplasms – is immunohistochemistry of help?
12.30 – 13.30
Lunch
13.30 – 14.15
A. Mróz – Everyday practice and future perspectives in colorectal pathology
14.15 – 15.00
A. Bellizzi – Problem-Based Approach to Pancreatic Pathology
15.00 – 15.30
Coffee Break
15.30 – 16.15
M. Eckstein – Differential ADC target expression in different morphological and molecular subtypes of urothelial carcinoma
16.15 – 17.00
M. Eckstein – Spatial transcriptomic profiling of metastatic renal cell carcinoma
17.00 – 18.00
CASE PRESENTATIONS (4 unusual cases)

08.30 – 09.15
K. Bøgh Anderson and S. Nielsen – Quality Review on Most Commonly Used IHC assays-Expectations, Disappointments and Challenges During Last Decade (NordiQC)
09.15 – 10.00
A. Marszałek – Quality of pathologist training in the immunohistochemistry and molecular biology in the EU
10.00 – 10.30
Coffee Break
10.30 – 11.15
G. Sauter – Large-scale Tissue Microarray resources for the identification and evaluation of critical IHC markers
11.15 – 12.00
J. Lasota – Histological, immunohistochemical, and molecular characteristics of dedifferentiated and undifferentiated melanomas, and their distinction from other malignant tumors by the DNA methylation classifier
12.00 – 13.00
Lunch
13.00 – 13.45
J. Klijanienko – Auxillary tests in diagnostic cytology
13.45 – 14.30
R. Jach and M. Trzeszcz – p16/Ki67 DS ICC in cervical cancer prevention: Bridging immunoprofile and clinical decision making
14.30 – 15.00
Coffee Break
15.00 – 15.30
K. Korski – Generation of virtual stains-can AI imitate chemistry?
15.30 – 16.00
Ż. Świderska-Chadaj – The role of computational pathology in predicting expression of selected immunohistochemical markers
16.00 – 16.30
Multimodal algorithms in digital pathology (be announced)
16.30
J. Rys – Closing remarks